ThirtyFiveBio Stealth Emergence
March 27, 20230
ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023 Third Company Created by M:M Bio and Jointly Incubated by Canaan Partners has Raised $20 Million to Date Pioneering a New Precision Medicine Approach to Gastrointestinal Diseases and Cancers through...
